On ECHEMI
Home > Drugs > Jinan Gaohua Pharmaceutical Co., Ltd.
Jinan Gaohua Pharmaceutical Co., Ltd.
  • Founded in:

    1994-12-22
  • Country:

    China China
  • Address:

    No. 8 Panwang Road, Mingshui Economic Development Zone, Longshan Street, Zhangqiu District, Jinan City, Shandong Province
  • Tax NO.:

    913701812644656618
  • Registered Funds:

    2.1 million yuan
  • Email:

Related Drugs
Indapamide
Name Description Content CAS NO. Registered Holders
Indapamide

Extract from the above information

More

Extract from the above information

26807-65-8 29
Enoxacin Tablets
Enoxacin.
Name Description Content CAS NO. Registered Holders
Enoxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

74011-58-8 4
Clemastine Fumarate
Name Description Content CAS NO. Registered Holders
Clemastine fumarate

Unspecified

More

Unspecified

14976-57-9 6
Clemastine Fumarate Tablets
The main ingredient is clemastine fumarate. Its chemical name is: [R-(R*, R*)]-1-methyl-2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-pyrrolidine (E)-2-butenedioate.
Name Description Content CAS NO. Registered Holders
Clemastine fumarate

H1 receptor antagonist, can inhibit the permeability of capillaries, can quickly stop itching. It also has anticholinergic and sedative effects.

More

H1 receptor antagonist, can inhibit the permeability of capillaries, can quickly stop itching. It also has anticholinergic and sedative effects.

14976-57-9 6
Indapamide extended-release tablets
The main ingredient of this product is: Indapamide.
Name Description Content CAS NO. Registered Holders
Indapamide

It acts on the dilution segment of the renal cortex, achieves a diuretic effect by inhibiting the reabsorption of sodium, increases the excretion of urinary sodium and chloride, and to a lesser extent increases the excretion of potassium and magnesium; improves arterial compliance, reduces the resistance of small arteries and the entire peripheral circulation, and can reverse left ventricular hypertrophy caused by hypertension; does not affect lipid metabolism and carbohydrate metabolism.

More

It acts on the dilution segment of the renal cortex, achieves a diuretic effect by inhibiting the reabsorption of sodium, increases the excretion of urinary sodium and chloride, and to a lesser extent increases the excretion of potassium and magnesium; improves arterial compliance, reduces the resistance of small arteries and the entire peripheral circulation, and can reverse left ventricular hypertrophy caused by hypertension; does not affect lipid metabolism and carbohydrate metabolism.

26807-65-8 29
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.